Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 04 Sept 2026 for AN2 Therapeutics, Inc., €1,295. Read the official filing
Filing timeline
BuySaleSarah Joanne Williams
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Sarah Joanne Williams: trading record in brief
All filings by Sarah Joanne Williams on record concern AN2 Therapeutics, Inc. In total, 4 filings cover trades dated from 20 February 2026 to 1 September 2026.
On the market, this insider has only sold: 3 sales, €2,602 in total. Outside the open market, there are 1 share grant.
On 4 September 2026 came the latest disclosure, an open-market sale for €1,295 in AN2 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sarah Joanne Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
272 shares@ US$5.530.0008% mcap49.8% of flowCommon StockSEC:0001193125-26-383697:0
265 shares@ US$4.430.0006% mcap38.8% of flowCommon StockSEC:0001193125-26-253622:0
327 shares@ US$1.0611.4% of flowCommon StockSEC:0001193125-26-094490:0
48,375 shares0Common StockSEC:0001193125-26-064166:0
4 of 4 declarations
